Market Closed

MRNA
Moderna
$ 223.37
-3.45%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Moderna News

Latest Moderna Stock News & MRNA Headlines

Axsome Therapeutics vs. Moderna: Which Biotech Innovator Stock Is a Better Buy for 2027?
a day ago | fool.com
Moderna Issues Cost Outlook Amid Revenue Uncertainty, Stock Falls
2 days ago | zacks.com
Moderna, Inc. $MRNA Stock Sold by Commonwealth Equity Services LLC
3 days ago | defenseworld.net
BioNTech May Be the Next Moderna. Even if it Isn't, the Stock Is a Buy.
3 days ago | barrons.com
Moderna Targets 2027 Cancer Therapy Launch, Raises 2026 Revenue Growth Outlook
3 days ago | marketbeat.com
MRNA Stock Up 3% Since Q3 Earnings Release: How to Play the Stock?
3 days ago | zacks.com
Why Moderna Stock Dropped on Thursday
3 days ago | fool.com
Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.
3 days ago | barrons.com
71 West Capital Partners Acquires New Holdings in Moderna, Inc. $MRNA
5 days ago | defenseworld.net
Moderna's Q3 Numbers May Have Seemed Impressive, but They Aren't Enough to Make the Stock a Buy
6 days ago | fool.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

MRNA
Moderna
$ 223.37
-3.45%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago